Dropless Pars Plana Vitrectomy Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dropless Pars Plana Vitrectomy Study — Stella

Home/Rhegmatogenous Retinal Detachment/

View on ClinicalTrials.gov

Recruiting

Back to Rhegmatogenous Retinal Detachment trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Massachusetts Eye and Ear, Boston, Massachusetts

Key details

Phase

Post-approval study

Sponsor

Massachusetts Eye and Ear Infirmary

Enrollment target

~168 participants

Started

July 2022

Primary completion

July 2026

Age range

40 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.